Vioxx recall rocks Merck&#39;s stock: Drug maker halts trial with ...
64708
Shares of Merck &amp; Co. plunged nearly 27 percent yesterday, pulling other stocks down with it, after the pharmaceutical giant yanked its Vioxx arthritis drug off the market because of heart safety concerns.
57265
Merck &amp; Co.&#39;s decision to pull its Vioxx anti-arthritis drug from the markets due to severe side effects left pharmaceutical sector mixed Thursday.
414077
NEW YORK -- Merck &amp; Co.'s campaign to defend itself in the wake of the recall of the pain reliever Vioxx intensified last week, as it placed a package of three full-page ads in seven prominent newspapers beginning last Friday. That follows several television appearances, as well as testimony before Congress by the company's chief executive.
519933
NEW YORK - Should Merck have conducted a bigger trial to test the safety of its arthritis drug Vioxx? Merck (nyse: MRK - news - people ) pulled Vioxx from the market two weeks ago, but questions about the
51395
Merck &amp; Co. withdrew the popular drug Vioxx from the market in September, after data from a clinical trial supported claims the medication was associated with an increased risk of heart attack and stroke.
446587
Merck & Company said that third-quarter earnings plunged 29 percent after the recall of its Vioxx painkiller.
318860
NEW YORK (CBS.MW) -- Merck (MRK) shares dipped almost 2 percent to $45.16, making it the biggest decliner in the Dow. The selling is related to just surfacing concerns about the safety of its Vioxx arthritis COX-2 inhibitor drug.
352365
Merck & Co Inc. MRK.N on Thursday  pulled its arthritis drug Vioxx off the market after a study  showed it doubled the risk of heart attack and stroke, a move  that sent its shares plunging and erased $25 billion from its  market value.
695075
The U.S. Dow Jones Industrial average declined on Thursday after drug maker Merck & Co. recalled its widely sold Vioxx painkiller and its stock sunk 27 percent.
33474
On September 30, 2004, Merck &amp; Co. announced the immediate recall of one of its COX-2 inhibitors, the anti-inflammatory drug VIOXXÂ®, because, in Merck&#39;s own words, a study it had been conducting showed that:
313849
Merck &amp; Co., under siege because of lost revenues from its recalled blockbuster arthritis drug Vioxx, will cut about 5,100 jobs by year&#39;s end, more than originally planned, and will slash hundreds of millions of dollars in spending, Chairman Raymond V
628834
Merck & Co Inc. on Thursday pulled its  arthritis drug Vioxx off the market after a study showed it  doubled the risk of heart attack and stroke, a move that sent  its shares plunging and erased $25 billion from its market  value.
437541
Shares of Merck and Co. plunged nearly 27 percent Thursday on news that the pharmaceutical giant was pulling the popular arthritis pain medication Vioxx off the market in the largest drug withdrawal in US history.
196745
Wall Street stock indexes closed out a dismal third quarter mixed Thursday after Merck &amp; Co. stated it would remove its best-selling Vioxx arthritis drug from the market.
769773
TRENTON, N.J. -- Shares of drug maker Merck &amp; Co. dropped 2.5 percent in heavy trading yesterday, a day after medical journal reports offered fresh ammunition to patients suing over its withdrawn painkiller Vioxx.
90172
Merck Labs has pulled Vioxx, their arthritis drug, off the market after discovering during trials the possibility of a link to stroke or heart attack.
570243
Merck & Co. MRK.N on Thursday said  its third-quarter profit fell, hurt by big charges for the  recall of the company's Vioxx arthritis drug in late September  after it was linked to heart attacks and strokes.